MEDXF - Medexus Pharmaceuticals Inc. (MEDXF) CEO Ken d'Entremont on Q4 2021 Results - Earnings Call Transcript

Start Time: 08:00 End Time: 08:41 Medexus Pharmaceuticals Inc. (MEDXF) Q4 2021 Earnings Conference Call June 17, 2021, 08:00 AM ET Company Participants Ken d’Entremont - CEO Roland Boivin - CFO Tina Byers - IR Conference Call Participants Andre Uddin - Research Capital Justin Keywood - Stifel GMP Presentation Operator Good day, ladies and gentlemen, and welcome to the Medexus Pharmaceuticals Inc. Fiscal 2021 Year End Business Update Conference Call. At this time, all participants have been placed on listen-only mode, and the floor will be open for questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, Tina Byers. Ma’am, the floor is yours. Tina Byers Thank you and good morning, everyone. Welcome to the Medexus Pharmaceuticals fourth quarter and fiscal year end 2021 earnings call. On the call this morning are Ken d’Entremont, Chief Executive Officer; and Roland Boivin,

For further details see:

Medexus Pharmaceuticals Inc. (MEDXF) CEO Ken d'Entremont on Q4 2021 Results - Earnings Call Transcript